Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2009 1
2010 3
2011 1
2014 1
2015 1
2016 1
2018 1
2019 1
2020 1
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
A potent bioactive fraction against colon cancer from Plectranthus vettiveroides.
Athikkavil FM, Aiswarya SU, Johny R, Sudhesh M, Nisthul AA, Lankalapalli RS, Anto RJ, Bava SV. Athikkavil FM, et al. Among authors: bava sv. Explor Target Antitumor Ther. 2023;4(2):227-239. doi: 10.37349/etat.2023.00131. Epub 2023 Apr 24. Explor Target Antitumor Ther. 2023. PMID: 37205312 Free PMC article.
Corrigendum: Cucurbitacin B, purified and characterized from the rhizome of Corallocarpus epigaeus exhibits anti-melanoma potential.
Aiswarya SUD, Vikas G, Haritha NH, Liju VB, Shabna A, Swetha M, Rayginia TP, Keerthana CK, Nath LR, Reshma MV, Sundaram S, Anto NP, Lankalapalli RS, Anto RJ, Bava SV. Aiswarya SUD, et al. Front Oncol. 2022 Aug 12;12:989283. doi: 10.3389/fonc.2022.989283. eCollection 2022. Front Oncol. 2022. PMID: 36033534 Free PMC article.
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Haritha NH, et al. Among authors: bava sv. Front Oncol. 2023 Dec 15;13:1302413. doi: 10.3389/fonc.2023.1302413. eCollection 2023. Front Oncol. 2023. PMID: 38162481 Free PMC article.
Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.
Shabna A, Antony J, Vijayakurup V, Saikia M, Liju VB, Retnakumari AP, Amrutha NA, Alex VV, Swetha M, Aiswarya SU, Jannet S, Unni US, Sundaram S, Sherin DR, Anto NP, Bava SV, Chittalakkottu S, Ran S, Anto RJ. Shabna A, et al. Among authors: bava sv. Cell Mol Life Sci. 2022 Aug 10;79(9):478. doi: 10.1007/s00018-022-04476-y. Cell Mol Life Sci. 2022. PMID: 35948813 Free PMC article.
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.
Haritha NH, Nawab A, Vijayakurup V, Anto NP, Liju VB, Alex VV, Amrutha AN, Aiswarya SU, Swetha M, Vinod BS, Sundaram S, Guijarro MV, Herlevich T, Krishna A, Nestory NK, Bava SV, Sadasivan C, Zajac-Kaye M, Anto RJ. Haritha NH, et al. Among authors: bava sv. Front Oncol. 2021 Jul 15;11:656804. doi: 10.3389/fonc.2021.656804. eCollection 2021. Front Oncol. 2021. PMID: 34336653 Free PMC article.
16 results